Literature DB >> 7780225

Postoperative changes in plasma tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.

K Aoki1, N Nishino, S Baba, T Urano, A Takada.   

Abstract

To clarify the changes which occur postoperatively in intravascular fibrinolysis, plasma levels of tissue-type plasminogen activator (t-PA) antigen, the total plasminogen activator inhibitor type-1 (PAI-1) antigen, and the t-PA-PAI-1 complexes were assayed in this study. Blood samples were taken the morning before surgery, then at 0, 12, 24, 36, 60, 108, and 156 h postoperatively in ten patients who underwent radical surgery for thoracic esophageal cancer. The plasma levels of the t-PA and total PAI-1 antigens, and the t-PA-PAI-1 complexes were then measured by enzyme immunoassay. The plasma t-PA and total PAI-1 levels increased significantly in the immediate postoperative period, the percent increase of the latter being much greater than that of the former. Moreover, the calculated free t-PA antigen level was decreased throughout the postoperative period, suggesting postoperative hypofibrinolysis. The platelet count and neutrophil elastase level were significantly correlated with the free t-PA antigen level at r = 0.630, P < 0.001, and r = -0.447, P < 0.01, respectively. The results of this study indicated that post-operative hypofibrinolysis caused by the increased synthesis of PAI-1 may enhance postoperative hypercoagulability, and this may lead to the development of organ damage. Thus, the concentration of the PAI-1 antigen may be a potentially important index for the prediction of postoperative illness.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7780225     DOI: 10.1007/bf01367453

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.

Authors:  T Urano; K Sakakibara; A Rydzewski; S Urano; Y Takada; A Takada
Journal:  Thromb Haemost       Date:  1990-02-19       Impact factor: 5.249

2.  Measurement of human tissue-type plasminogen activator by a two-site immunoradiometric assay.

Authors:  D C Rijken; I Juhan-Vague; F de Cock; D Collen
Journal:  J Lab Clin Med       Date:  1983-02

3.  Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.

Authors:  P A Andreasen; C Pyke; A Riccio; P Kristensen; L S Nielsen; L R Lund; F Blasi; K Danø
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

4.  Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions.

Authors:  I Juhan-Vague; B Moerman; F De Cock; M F Aillaud; D Collen
Journal:  Thromb Res       Date:  1984-03-01       Impact factor: 3.944

5.  PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA.

Authors:  T Urano; K Sumiyoshi; M H Pietraszek; Y Takada; A Takada
Journal:  Thromb Haemost       Date:  1991-10-01       Impact factor: 5.249

6.  Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.

Authors:  T D Gelehrter; R Sznycer-Laszuk
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

7.  Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.

Authors:  M Colucci; J A Paramo; D Collen
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

Review 8.  Some recent advances in the chemistry and biology of transforming growth factor-beta.

Authors:  M B Sporn; A B Roberts; L M Wakefield; B de Crombrugghe
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

9.  The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells.

Authors:  O Saksela; D Moscatelli; D B Rifkin
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

10.  Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells.

Authors:  J J Emeis; T Kooistra
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  4 in total

1.  Expression of MMP9, SERPINE1 and miR-134 as prognostic factors in esophageal cancer.

Authors:  Anna Agnieszka Klimczak-Bitner; Radzisław Kordek; Jan Bitner; Jacek Musiał; Janusz Szemraj
Journal:  Oncol Lett       Date:  2016-09-29       Impact factor: 2.967

2.  Pulmonary thromboembolism after surgery for esophageal cancer: its features and prophylaxis.

Authors:  K Tsutsumi; H Udagawa; Y Kajiyama; Y Kinoshita; M Ueno; T Nakamura; M Tsurumaru; H Akiyama
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

3.  Early coagulation disorders after severe burn injury: impact on mortality.

Authors:  Athina Lavrentieva; Theodore Kontakiotis; Militsa Bitzani; Georgia Papaioannou-Gaki; Angeliki Parlapani; Olimpia Thomareis; Nicolaos Tsotsolis; Maria-Amalia Giala
Journal:  Intensive Care Med       Date:  2008-01-12       Impact factor: 17.440

Review 4.  The Underestimated Role of Platelets in Severe Infection a Narrative Review.

Authors:  Alberto Fogagnolo; Gianluca Calogero Campo; Matilde Mari; Graziella Pompei; Rita Pavasini; Carlo Alberto Volta; Savino Spadaro
Journal:  Cells       Date:  2022-01-26       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.